BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BLDR • US12008R1077

119.48 USD
-4.32 (-3.49%)
Last: Feb 5, 2026, 10:28 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BLDR. BLDR was compared to 42 industry peers in the Building Products industry. BLDR has only an average score on both its financial health and profitability. BLDR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BLDR was profitable.
  • In the past year BLDR had a positive cash flow from operations.
  • In the past 5 years BLDR has always been profitable.
  • BLDR had a positive operating cash flow in each of the past 5 years.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

  • BLDR has a Return On Assets (5.20%) which is in line with its industry peers.
  • BLDR has a Return On Equity (13.76%) which is comparable to the rest of the industry.
  • BLDR has a Return On Invested Capital of 8.34%. This is comparable to the rest of the industry: BLDR outperforms 47.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BLDR is significantly above the industry average of 12.36%.
  • The last Return On Invested Capital (8.34%) for BLDR is well below the 3 year average (22.36%), which needs to be investigated, but indicates that BLDR had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROIC 8.34%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • BLDR has a worse Profit Margin (3.79%) than 61.90% of its industry peers.
  • In the last couple of years the Profit Margin of BLDR has grown nicely.
  • BLDR has a Operating Margin of 6.57%. This is in the lower half of the industry: BLDR underperforms 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of BLDR has grown nicely.
  • Looking at the Gross Margin, with a value of 30.97%, BLDR is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • BLDR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLDR is creating value.
  • BLDR has less shares outstanding than it did 1 year ago.
  • BLDR has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BLDR is higher compared to a year ago.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • BLDR has an Altman-Z score of 2.99. This is not the best score and indicates that BLDR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.99, BLDR perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
  • BLDR has a debt to FCF ratio of 4.35. This is a neutral value as BLDR would need 4.35 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 4.35, BLDR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that BLDR has dependencies on debt financing.
  • BLDR has a worse Debt to Equity ratio (1.03) than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Altman-Z 2.99
ROIC/WACC0.94
WACC8.91%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.79 indicates that BLDR should not have too much problems paying its short term obligations.
  • BLDR has a Current ratio of 1.79. This is in the lower half of the industry: BLDR underperforms 61.90% of its industry peers.
  • BLDR has a Quick Ratio of 1.15. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • BLDR has a Quick ratio of 1.15. This is comparable to the rest of the industry: BLDR outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.15
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for BLDR have decreased strongly by -36.73% in the last year.
  • BLDR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.71% yearly.
  • The Revenue has decreased by -6.44% in the past year.
  • BLDR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.64% yearly.
EPS 1Y (TTM)-36.73%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-38.76%
Revenue 1Y (TTM)-6.44%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-6.88%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.90% on average over the next years.
  • Based on estimates for the next years, BLDR will show a small growth in Revenue. The Revenue will grow by 1.08% on average per year.
EPS Next Y-37.67%
EPS Next 2Y-26.07%
EPS Next 3Y-11.23%
EPS Next 5Y-2.9%
Revenue Next Year-7.2%
Revenue Next 2Y-3.93%
Revenue Next 3Y-0.73%
Revenue Next 5Y1.08%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.79 indicates a correct valuation of BLDR.
  • 69.05% of the companies in the same industry are more expensive than BLDR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, BLDR is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 18.96, BLDR is valued on the expensive side.
  • BLDR's Price/Forward Earnings is on the same level as the industry average.
  • BLDR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 14.79
Fwd PE 18.96
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 64.29% of the companies in the same industry are more expensive than BLDR, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, BLDR is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.95
EV/EBITDA 11.11
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • BLDR has a very decent profitability rating, which may justify a higher PE ratio.
  • BLDR's earnings are expected to decrease with -11.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y-26.07%
EPS Next 3Y-11.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BLDR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (2/5/2026, 10:28:55 AM)

119.48

-4.32 (-3.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)10-30
Earnings (Next)02-17
Inst Owners104.69%
Inst Owner Change-3.6%
Ins Owners2.49%
Ins Owner Change0.09%
Market Cap13.21B
Revenue(TTM)15.65B
Net Income(TTM)593.96M
Analysts72.67
Price Target134.03 (12.18%)
Short Float %4.42%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.43%
Min EPS beat(2)2.38%
Max EPS beat(2)12.49%
EPS beat(4)4
Avg EPS beat(4)8.92%
Min EPS beat(4)2.38%
Max EPS beat(4)12.49%
EPS beat(8)8
Avg EPS beat(8)12.55%
EPS beat(12)12
Avg EPS beat(12)24.1%
EPS beat(16)16
Avg EPS beat(16)36.2%
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-5.53%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)0.31%
Revenue beat(8)2
Avg Revenue beat(8)-3.83%
Revenue beat(12)5
Avg Revenue beat(12)-2.18%
Revenue beat(16)9
Avg Revenue beat(16)1.88%
PT rev (1m)-0.85%
PT rev (3m)-5.28%
EPS NQ rev (1m)-0.63%
EPS NQ rev (3m)8.35%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)3.83%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-2.73%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 14.79
Fwd PE 18.96
P/S 0.84
P/FCF 12.95
P/OCF 9.47
P/B 3.06
P/tB N/A
EV/EBITDA 11.11
EPS(TTM)8.08
EY6.76%
EPS(NY)6.3
Fwd EY5.27%
FCF(TTM)9.23
FCFY7.72%
OCF(TTM)12.61
OCFY10.56%
SpS141.55
BVpS39.03
TBVpS-7.92
PEG (NY)N/A
PEG (5Y)0.36
Graham Number84.24
Profitability
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROCE 10.73%
ROIC 8.34%
ROICexc 8.6%
ROICexgc 19.5%
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
FCFM 6.52%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexgc growth 3Y-14.33%
ROICexgc growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Debt/EBITDA 2.76
Cap/Depr 64.9%
Cap/Sales 2.39%
Interest Coverage 4.4
Cash Conversion 86.87%
Profit Quality 171.79%
Current Ratio 1.79
Quick Ratio 1.15
Altman-Z 2.99
F-Score5
WACC8.91%
ROIC/WACC0.94
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.73%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-38.76%
EPS Next Y-37.67%
EPS Next 2Y-26.07%
EPS Next 3Y-11.23%
EPS Next 5Y-2.9%
Revenue 1Y (TTM)-6.44%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-6.88%
Revenue Next Year-7.2%
Revenue Next 2Y-3.93%
Revenue Next 3Y-0.73%
Revenue Next 5Y1.08%
EBIT growth 1Y-42.25%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year1.94%
EBIT Next 3Y3.06%
EBIT Next 5Y5.19%
FCF growth 1Y-52.65%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-47.7%
OCF growth 3Y2.41%
OCF growth 5Y30.02%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 6 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -37.67% in the next year.